Centers for Disease Control and Prevention
CDC Home Search Health Topics A-Z

OD/ADS Technology Transfer Office
Technology Transfer Office
TTO Home About Us  | Technology | Forms | What's New | Contact Us

Tech Transfer Office
TTO Home
About Us
Technology
Forms
What's New
Contact Us
Related Links
  
Multiple Antigenic Peptide Assay for Detection of HIV or SIV Type Retroviruses

Human immunodefeciency virus (HIV) is subdivided into 2 types, HIV-1 and HIV-2, both of which are believed to be the result of zoonotic transmission. Humans are being increasingly exposed to many different simian immunodeficiency viruses (SIVs) in wild primates, for example through the hunting and butchering trade in Africa. This human exposure to SIVs may lead, or has already led, to transmission of SIVs with the potential to cause new epidemics. Unfortunately, new zoonotic transmissions may go undetected because of the lack of SIV-specific tests. Thus, there is the potential to compromise the safety of the blood donor supply system and possibly to seed a new HIV-like epidemic. This invention addresses these problems by providing a way to test for the many divergent strains in monkeys and humans to identify primary infection and prevent secondary transmission.

Inventors: Marcia Kalish, Clement Ndongmo, Chou-Pong Pou, William Switzer, Thomas Folks

CDC Reference Number: I-023-02/0

USPTO Serial Number: 60/462,071

Patent Number:


 
 

TTO Home | About Us | Technology | Forms | What's New | Contact Us

CDC Home | Search | Health Topics A-Z

This page last reviewed November 13, 2003
Centers for Disease Control and Prevention
Office of Director
Technology Transfer Office